Fermented poi in pregnancy, body bacteria and gestational diabetes risk
Tests daily fermented poi in pregnancy to study gestational diabetes risk.
Key facts
- Who runs it
- University of Hawaii
- Where
- Honolulu and Waimanalo, United StatesSee the 3 sites
- Trial code
- Registry title
- Poi for Mama: a Pilot to Improve Maternal Microbiome and Gestational Diabetes Risk
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 12 Jun 2026
- Expected to end
- 31 Jan 2027
- Type of study
- Interventional
- Treatments tested
- Fermented Poi
- Record updated
- 2 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for pregnant women with no earlier health conditions who live on the windward side of O'ahu. They will eat fermented poi daily for four weeks.
- Age
- 18 years and older
- Sex
- Women only
- Disease stage
- At least 10 weeks pregnant and not yet in the third trimester.
Main reasons for not taking part
- Less than 10 weeks pregnant or already in the third trimester
- Health conditions present before the pregnancy
- Not able to read and write in English
- No smartphone
- Not living on the windward side of O'ahu
This trial only enrols pregnant participants. The registry sentence this rests on: * Be at least 10 weeks into their pregnancy
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Be at least 10 weeks into their pregnancy
- have no pre-existing health conditions
- Be able to read and write in English
- be at least18 years of age
- Own a smartphone
- Live on the windward side of O'ahu
- Be able to complete study activities
Who cannot take part
- Have pre-existing health conditions
- Under 18 years of age
- Less than 10 weeks pregnant or already in third trimester
- Not able to read and write in English
- Do not own a smartphone
- Do not live on the windward side of O'ahu
- Unable to complete study activities
Where in United States
- Hawaii Pacific HealthHonolulu, United StatesContact: Marie Kainoa Fialkowski RevillaTaking people
- University of Hawai'i Cancer CenterHonolulu, United StatesContact: Marie Kainoa Fialkowski RevillaTaking people
- Waimānalo Health CenterWaimanalo, United StatesContact: Marie Kainoa Fialkowski RevillaTaking people
About the trial
What the trial wants to find out
This investigator-initiated, non-randomized pilot study evaluates the effect of daily consumption of fermented poi on the maternal microbiome and gestational diabetes risk during pregnancy. Fifty pregnant participants between approximately 12 and 24 weeks of gestation will receive one pound of poi daily for four weeks, accompanied by culturally tailored nutrition education delivered via secure text messaging. Changes in vaginal, oral, and rectal microbiome composition, diet quality, gestational diabetes diagnosis, and pregnancy-related outcomes will be assessed and compared with matched controls derived from an existing cohort. This study aims to inform the feasibility and design of a larger culturally grounded dietary intervention for gestational diabetes prevention.
The group in the trial
- Poi InterventionTreatment being tested
Daily consumption of fermented poi for 4 weeks during the second trimester.
Treatment: Fermented Poi
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Poi for Mama: a Pilot to Improve Maternal Microbiome and Gestational Diabetes Risk
- Plain-language title
- Fermented poi in pregnancy, body bacteria and gestational diabetes riskGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 2 July 2026